Literature DB >> 10657898

BTG gene expression in the p53-dependent and -independent cellular response to DNA damage.

U Cortes1, C Moyret-Lalle, N Falette, C Duriez, F E Ghissassi, C Barnas, A P Morel, P Hainaut, J P Magaud, A Puisieux.   

Abstract

Exposure of mammalian cells to genotoxic agents evokes a complex cellular response. An ordered series of molecular events is necessary to sense DNA damage, transduce the signal, and ultimately delay the cell cycle or trigger apoptosis. Recently, we have shown that BTG2/TIS21 gene expression was induced in response to DNA damage through a p53-dependent pathway. This gene belongs to a newly identified family of structurally related genes whose other known human members are BTG1, BTG3, and Tob. To define the respective involvement of these four related genes in the cellular response to DNA damage, we studied their expression in human cell lines after a variety of genotoxic treatments. Our results demonstrated that were BTG1, BTG2/TIS21, and Tob genes the DNA damage--inducible genes. However, BTG2/TIS21 appeared to be the only p53-transcriptional target gene. We speculate that BTG proteins may play a coordinate role in a general transduction pathway that is induced in response to DNA damage. It has been previously described that recombinant BTG1 and BTG2/TIS21 can physically interact with PRMT1, an arginine methyl transferase, suggesting that BTG1 and BTG2/TIS21 induction may lead to posttranslational modifications of cellular proteins. In support of this hypothesis, we showed that the endogenous induction of BTG1 and BTG2 after genotoxic treatment was correlated with a modulation of protein methylation. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657898

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  37 in total

1.  Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent.

Authors:  Bey-Dih Chang; Mari E Swift; Mei Shen; Jing Fang; Eugenia V Broude; Igor B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Identification of BTG1 Status in Solid Cancer for Future Researches Using a System Review and Meta-analysis.

Authors:  Xiu-Qiong Chen; Fan-Qiao Meng; Hua Xiong; Ya-Li Wang; Wen-Hua Tang; Yan-Mei Zou
Journal:  Curr Med Sci       Date:  2020-03-13

3.  Mitogen-stimulated TIS21 protein interacts with a protein-kinase-Calpha-binding protein rPICK1.

Authors:  W J Lin; Y F Chang; W L Wang; C Y Huang
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

4.  Btg2 enhances retinoic acid-induced differentiation by modulating histone H4 methylation and acetylation.

Authors:  Daniela Passeri; Antonella Marcucci; Giovanni Rizzo; Monia Billi; Maddalena Panigada; Luca Leonardi; Felice Tirone; Francesco Grignani
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

5.  The Extended ToxTracker Assay Discriminates Between Induction of DNA Damage, Oxidative Stress, and Protein Misfolding.

Authors:  Giel Hendriks; Remco S Derr; Branislav Misovic; Bruno Morolli; Fabienne M G R Calléja; Harry Vrieling
Journal:  Toxicol Sci       Date:  2015-12-29       Impact factor: 4.849

6.  Transcriptional regulation of thymine DNA glycosylase (TDG) by the tumor suppressor protein p53.

Authors:  Nathalia Meireles da Costa; Agnès Hautefeuille; Marie-Pierre Cros; Matias Eliseo Melendez; Timothy Waters; Peter Swann; Pierre Hainaut; Luis Felipe Ribeiro Pinto
Journal:  Cell Cycle       Date:  2012-11-19       Impact factor: 4.534

7.  Analysis of differential gene expression by bead-based fiber-optic array in growth-hormone-secreting pituitary adenomas.

Authors:  Zhiquan Jiang; Songbo Gui; Yazhuo Zhang
Journal:  Exp Ther Med       Date:  2010-07-21       Impact factor: 2.447

8.  Estrogen receptor prevents p53-dependent apoptosis in breast cancer.

Authors:  Shannon T Bailey; Hyunjin Shin; Thomas Westerling; Xiaole Shirley Liu; Myles Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-17       Impact factor: 11.205

9.  BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma.

Authors:  G G Sun; Y D Wang; Y J Cheng; W N Hu
Journal:  Tumour Biol       Date:  2014-06-27

10.  Mice lacking a transcriptional corepressor Tob are predisposed to cancer.

Authors:  Yutaka Yoshida; Takahisa Nakamura; Masato Komoda; Hitoshi Satoh; Toru Suzuki; Junko K Tsuzuku; Takashi Miyasaka; Eri H Yoshida; Hisashi Umemori; Reiko K Kunisaki; Kenzaburo Tani; Shunsuke Ishii; Shigeo Mori; Masami Suganuma; Tetsuo Noda; Tadashi Yamamoto
Journal:  Genes Dev       Date:  2003-05-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.